Treatment outcome of doxorubicin versus idarubicin in adult acute myeloid leukemia

PURPOSE: The present study aimed to compare treatment outcome of idarubicin versus doxorubicin in combination with Ara-C as induction therapy for untreated AML patients. PATIENTS AND METHODS: This retrospective study included 143 patients with de novo AML. All patients received full dose of standard...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherif, Hemat Afifi, Magdy, Ahmed, Elshesheni, Heba Anees, Ramadan, Sherein Mahmoud, Rashed, Reham A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517376/
https://www.ncbi.nlm.nih.gov/pubmed/34692402
http://dx.doi.org/10.1016/j.lrr.2021.100272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517376/
https://www.ncbi.nlm.nih.gov/pubmed/34692402
http://dx.doi.org/10.1016/j.lrr.2021.100272

Ejemplares similares